世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000032557

2031年までのインフルエンザ診断の世界市場の機会と戦略

The Business Research Company

Influenza Diagnostics Global Market Opportunities And Strategies To 2031

発刊日 2022/07/07

言語英語

体裁PDF/303ページ

ライセンス/価格303ページ

0000032557

Single
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※受注後、レポートは最新版へ更新されますので、納品までに3〜5営業日かかります。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、戦略担当者、マーケティング担当者、経営幹部に、COVID 19のシャットダウンから出現する世界のインフルエンザ診断市場を評価するために必要な重要な情報を提供します。

調査範囲

  • 調査市場
    ➣ 従来の診断検査別
      ◇ インフルエンザ迅速診断検査(RIDT)
      ◇ ウイルス培養
      ◇ DFA
      ◇ 血清学的アッセイ
      ◇ その他
    ➣ 分子診断検査別
      ◇ 逆転写ポリメラーゼ連鎖反応(RT-PCR)
      ◇ 等温核酸増幅検査
      ◇ LAMP法
      ◇ 転写媒介等温ベース増幅アッセイ
      ◇ その他の等温核酸増幅検査
    ➣ エンドユーザー別
      ◇ 病院・臨床ラボ
      ◇ 診断リファレンスラボ
      ◇ 学術機関/研究機関
      ◇ その他
  • 調査企業
    ➣ Abbott Laboratories
    ➣ F. Hoffmann-La Roche Ltd.
    ➣ Becton, Dickinson and Company
    ➣ Thermo Fisher Scientific Inc.
    ➣ Quidel Corp
  • 調査国
    ➣ 中国
    ➣ オーストラリア
    ➣ インド
    ➣ インドネシア
    ➣ 日本
    ➣ 韓国
    ➣ アメリカ
    ➣ ブラジル
    ➣ フランス
    ➣ ドイツ
    ➣ イギリス
    ➣ ロシア
  • 調査地域
    ➣ アジア太平洋地域
    ➣ 西ヨーロッパ
    ➣ 東ヨーロッパ
    ➣ 北アメリカ
    ➣ 南アメリカ
    ➣ 中東
    ➣ アフリカ
  • 調査期間
    ➣ 5年間の実績データおよび10年間の予測
  • データ
    ➣ 市場規模と成長率の関連市場に対する比率
    ➣ GDP比率
    ➣ 一人当たりの支出
    ➣ インフルエンザ診断の指標比較
  • データセグメント
    ➣ 国別・地域別の実績および予測データ
    ➣ 競合企業の市場シェア
    ➣ 市場セグメント
  • 情報源および参照
    ➣ 本レポートのデータおよび分析は、注釈で出典を明らかにしています。

レポート詳細

目次

Table of Contents

1. Influenza Diagnostics Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction
6.1.1. Segmentation By Geography
6.1.2. Segmentation By Traditional Diagnostic Tests
6.1.3. Segmentation By Molecular Diagnostic Tests
6.1.4. Segmentation By End-User

7. Influenza Diagnostics Market Characteristics
7.1. Market Definition
7.2. Segmentation By Traditional Diagnostic Tests
7.2.1. Rapid Influenza Diagnostic Tests (RIDT)
7.2.2. Viral Culture
7.2.3. DFA
7.2.4. Serological Assays
7.2.5. Others
7.3. Segmentation By Molecular Diagnostic Tests
7.3.1. Reverse Transcription Polymerase Chain Reaction (RT-PCR)
7.3.2. Isothermal Nucleic Acid Amplification Test
7.3.3. Loop-Mediated Isothermal Based Amplification Assays (LAMP)
7.3.4. Transcription Mediated Isothermal Based Amplification Assays
7.3.5. Other Isothermal Nucleic Acid Amplification Tests
7.4. Segmentation By End User
7.4.1. Hospitals and Clinical Laboratories
7.4.2. Diagnostic Reference Laboratories
7.4.3. Academic/Research Institutes
7.4.4. Others

8. Influenza Diagnostics Market Trends And Strategies
8.1. Strategic Partnerships and Acquisitions
8.2. Use Of Artificial Intelligence
8.3. Collaborations Between Governments And Manufacturers
8.4. At-Home Test Kits
8.5. Supportive Government Funding and Initiatives

9. Impact Of COVID-19 On Influenza Diagnostics Market
9.1. Introduction
9.2. Impact on Influenza Diagnostic Testing
9.3. Promotion Of Flu Vaccination During The COVID-19 Pandemic
9.4. Impact On Companies Revenue
9.5. Future Outlook

10. Global Influenza Diagnostics Market Size And Growth
10.1. Market Size
10.2. Historic Market Growth, 2016 - 2021, Value ($ Million)
10.2.1. Drivers Of The Market 2016 - 2021
10.2.2. Restraints On The Market 2016 - 2021
10.3. Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
10.3.1. Drivers Of The Market 2021 - 2026
10.3.2. Restraints On The Market 2021 - 2026

11. Global Influenza Diagnostics Market Segmentation
11.1. Global Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.2. Global Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.3. Global Influenza Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

12. Influenza Diagnostics Market, Regional And Country Analysis
12.1. Global Influenza Diagnostics Market, By Region, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.2. Global Influenza Diagnostics Market, By Country, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

13. Asia-Pacific Influenza Diagnostics Market
13.1. Asia-Pacific Influenza Diagnostics Market Overview
13.1.1. Region Information
13.1.2. Market Information
13.1.3. Background Information
13.1.4. Government Initiatives
13.1.5. Regulations
13.1.6. Regulatory Bodies
13.1.7. Major Associations
13.1.8. Taxes Levied
13.1.9. Corporate Tax Structure
13.1.10. Investments
13.1.11. Major Companies
13.2. Asia-Pacific Influenza Diagnostics Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.3. Asia-Pacific Influenza Diagnostics Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.4. Asia-Pacific Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.5. Asia-Pacific Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.6. China Influenza Diagnostics Market
13.7. China Influenza Diagnostics Market Overview
13.7.1. Country Information
13.7.2. Market Information
13.7.3. Background Information
13.7.4. Government Initiatives
13.7.5. Regulations
13.7.6. Regulatory Bodies
13.7.7. Major Associations
13.7.8. Taxes Levied
13.7.9. Corporate Tax Structure
13.7.10. Investments
13.7.11. Major Companies
13.8. China Influenza Diagnostics Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.9. China Influenza Diagnostics Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.10. China Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.11. China Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.12. India Influenza Diagnostics Market
13.13. India Influenza Diagnostics Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.14. India Influenza Diagnostics Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.15. India Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.16. India Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.17. Japan Influenza Diagnostics Market
13.18. Japan Influenza Diagnostics Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.19. Japan Influenza Diagnostics Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.20. Japan Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.21. Japan Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.22. Australia Influenza Diagnostics Market
13.23. Australia Influenza Diagnostics Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.24. Australia Influenza Diagnostics Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.25. Australia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.26. Australia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.27. Indonesia Influenza Diagnostics Market
13.28. Indonesia Influenza Diagnostics Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.29. Indonesia Influenza Diagnostics Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.30. Indonesia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.31. Indonesia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.32. South Korea Influenza Diagnostics Market
13.33. South Korea Influenza Diagnostics Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.34. South Korea Influenza Diagnostics Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.35. South Korea Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.36. South Korea Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

14. Western Europe Influenza Diagnostics Market
14.1. Western Europe Influenza Diagnostics Market Overview
14.1.1. Region Information
14.1.2. Market Information
14.1.3. Background Information
14.1.4. Government Initiatives
14.1.5. Regulations
14.1.6. Regulatory Bodies
14.1.7. Major Associations
14.1.8. Taxes Levied
14.1.9. Corporate Tax Structure
14.1.10. Investments
14.1.11. Major Companies
14.2. Western Europe Influenza Diagnostics Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.3. Western Europe Influenza Diagnostics Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.4. Western Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.5. Western Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.6. Western Europe Influenza Diagnostics Market: Country Analysis
14.7. UK Influenza Diagnostics Market
14.8. UK Influenza Diagnostics Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.9. UK Influenza Diagnostics Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.10. UK Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.11. UK Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.12. Germany Influenza Diagnostics Market
14.13. Germany Influenza Diagnostics Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.14. Germany Influenza Diagnostics Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.15. Germany Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.16. Germany Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.17. France Influenza Diagnostics Market
14.18. France Influenza Diagnostics Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.19. France Influenza Diagnostics Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.20. France Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.21. France Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

15. Eastern Europe Influenza Diagnostics Market
15.1. Eastern Europe Influenza Diagnostics Market Overview
15.1.1. Region Information
15.1.2. Market Information
15.1.3. Background Information
15.1.4. Government Initiatives
15.1.5. Regulations
15.1.6. Regulatory Bodies
15.1.7. Major Associations
15.1.8. Taxes Levied
15.1.9. Corporate Tax Structure
15.1.10. Investments
15.1.11. Major Companies
15.2. Eastern Europe Influenza Diagnostics Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.3. Eastern Europe Influenza Diagnostics Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.4. Eastern Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.5. Eastern Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.6. Eastern Europe Influenza Diagnostics Market: Country Analysis
15.7. Russia Influenza Diagnostics Market
15.8. Russia Influenza Diagnostics Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.9. Russia Influenza Diagnostics Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.10. Russia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.11. Russia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

16. North America Influenza Diagnostics Market
16.1. North America Influenza Diagnostics Market Overview
16.1.1. Region Information
16.1.2. Market Information
16.1.3. Background Information
16.1.4. Government Initiatives
16.1.5. Regulatory Bodies
16.1.6. Regulations
16.1.7. Major Associations
16.1.8. Taxes Levied
16.1.9. Corporate tax structure
16.1.10. Investments
16.1.11. Major Companies
16.2. North America Influenza Diagnostics Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.3. North America Influenza Diagnostics Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.4. North America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.5. North America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.6. USA Influenza Diagnostics Market
16.7. USA Influenza Diagnostics Market Overview
16.7.1. Country Information
16.7.2. Market Information
16.7.3. Background Information
16.7.4. Government Initiatives
16.7.5. Regulatory Bodies
16.7.6. Regulations
16.7.7. Major Associations
16.7.8. Taxes Levied
16.7.9. Corporate Tax Structure
16.7.10. Investments
16.7.11. Major Companies
16.8. USA Influenza Diagnostics Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.9. USA Influenza Diagnostics Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.10. USA Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.11. USA Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

17. South America Influenza Diagnostics Market
17.1. South America Influenza Diagnostics Market Overview
17.1.1. Region Information
17.1.2. Market Information
17.1.3. Background Information
17.1.4. Government Initiatives
17.1.5. Regulations
17.1.6. Regulatory Bodies
17.1.7. Major Associations
17.1.8. Taxes Levied
17.1.9. Corporate Tax Structure
17.1.10. Investments
17.1.11. Major Companies
17.2. South America Influenza Diagnostics Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
17.3. South America Influenza Diagnostics Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
17.4. South America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.5. South America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.6. South America Influenza Diagnostics Market: Country Analysis
17.7. Brazil Influenza Diagnostics Market
17.8. Brazil Influenza Diagnostics Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
17.9. Brazil Influenza Diagnostics Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
17.10. Brazil Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.11. Brazil Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

18. Middle East Influenza Diagnostics Market
18.1. Middle East Influenza Diagnostics Market Overview
18.1.1. Region Information
18.1.2. Market Information
18.1.3. Background Information
18.1.4. Government Initiatives
18.1.5. Regulations
18.1.6. Regulatory Bodies
18.1.7. Major Associations
18.1.8. Taxes Levied
18.1.9. Corporate Tax Structure
18.1.10. Investments
18.1.11. Major Companies
18.2. Middle East Influenza Diagnostics Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
18.3. Middle East Influenza Diagnostics Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
18.4. Middle East Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
18.5. Middle East Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

19. Africa Influenza Diagnostics Market
19.1. Africa Influenza Diagnostics Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. Background Information
19.1.4. Government Initiatives
19.1.5. Regulations
19.1.6. Regulatory Bodies
19.1.7. Major Associations
19.1.8. Taxes Levied
19.1.9. Corporate Tax Structure
19.1.10. Investments
19.1.11. Major Companies
19.2. Africa Influenza Diagnostics Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
19.3. Africa Influenza Diagnostics Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
19.4. Africa Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
19.5. Africa Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

20. Influenza Diagnostics Market Competitive Landscape And Company Profiles
20.1. Company Profiles
20.2. Abbott Laboratories
20.2.1. Company Overview
20.2.2. Products And Services
20.2.3. Business Strategy
20.2.4. Financial Overview
20.3. F. Hoffmann-La Roche Ltd
20.3.1. Company Overview
20.3.2. Products And Services
20.3.3. Business Strategy
20.3.4. Financial Overview
20.4. Becton, Dickinson and Company
20.4.1. Company Overview
20.4.2. Products And Services
20.4.3. Financial Overview
20.5. Thermo Fisher Scientific Inc
20.5.1. Company Overview
20.5.2. Products And Services
20.5.3. Business Strategy
20.5.4. Financial Overview
20.6. Quidel Corporation
20.6.1. Company Overview
20.6.2. Products And Services
20.6.3. Business Strategy
20.6.4. Financial Overview

21. Key Mergers And Acquisitions In The Influenza Diagnostics Market
21.1. Becton, Dickinson and Company Acquired Scanwell Health
21.2. Roche Acquired TIB Molbiol Group
21.3. Mylab Discovery Solutions Partnered With Hemex Health
21.4. Roche Acquired GenMark Diagnostics
21.5. Hologic Acquired Mobidiag Oy
21.6. DiaSorin Acquired Luminex
21.7. Thermo Fisher Acquired Mesa Biotech
21.8. Becton Dickinson Acquired NAT Diagnostics
21.9. Meridian Bioscience Inc Acquired GenePoc Inc

22. Influenza Diagnostics Market Opportunities And Strategies
22.1. Global Influenza Diagnostics Market In 2026 - Countries Offering Most New Opportunities
22.2. Global Influenza Diagnostics Market In 2026 - Segments Offering Most New Opportunities
22.3. Global Influenza Diagnostics Market In 2026 - Growth Strategies
22.3.1. Market Trend Based Strategies
22.3.2. Competitor Strategies

23. Influenza Diagnostics Market, Conclusions And Recommendations
23.1. Conclusions
23.2. Recommendations
23.2.1. Product
23.2.2. Place
23.2.3. Price
23.2.4. Promotion
23.2.5. People

24. Appendix
24.1. Market Data Sources
24.2. Research Methodology
24.3. Currencies
24.4. Research Inquiries
24.5. The Business Research Company
24.6. Copyright and Disclaimer

この商品のレポートナンバー

0000032557

TOP